To include your compound in the COVID-19 Resource Center, submit it here.

ASM 981 pimecrolimus: Phase II

In a double-blind, dose-ranging, placebo-controlled European Phase II trial

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE